Skip to main content

New combinations in metastatic colorectal cancer: what are our expectations?

Publication ,  Journal Article
Hurwitz, H
Published in: Oncologist
May 2005

Duke Scholars

Published In

Oncologist

DOI

ISSN

1083-7159

Publication Date

May 2005

Volume

10

Issue

5

Start / End Page

320 / 322

Location

England

Related Subject Headings

  • Oxaliplatin
  • Organoplatinum Compounds
  • Oncology & Carcinogenesis
  • Irinotecan
  • Humans
  • Fluorouracil
  • Colorectal Neoplasms
  • Cetuximab
  • Camptothecin
  • Bevacizumab
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hurwitz, H. (2005). New combinations in metastatic colorectal cancer: what are our expectations? Oncologist, 10(5), 320–322. https://doi.org/10.1634/theoncologist.10-5-320
Hurwitz, Herbert. “New combinations in metastatic colorectal cancer: what are our expectations?Oncologist 10, no. 5 (May 2005): 320–22. https://doi.org/10.1634/theoncologist.10-5-320.
Hurwitz, Herbert. “New combinations in metastatic colorectal cancer: what are our expectations?Oncologist, vol. 10, no. 5, May 2005, pp. 320–22. Pubmed, doi:10.1634/theoncologist.10-5-320.

Published In

Oncologist

DOI

ISSN

1083-7159

Publication Date

May 2005

Volume

10

Issue

5

Start / End Page

320 / 322

Location

England

Related Subject Headings

  • Oxaliplatin
  • Organoplatinum Compounds
  • Oncology & Carcinogenesis
  • Irinotecan
  • Humans
  • Fluorouracil
  • Colorectal Neoplasms
  • Cetuximab
  • Camptothecin
  • Bevacizumab